Pomalong 4mg Price Bulk US Pharmaceutical Importer | Ernest Impex

Extensive Product Profile: In-Depth Insights on Pomalong 4mg Capsules

1. Clinical Indications & Target Therapeutic Applications

• Relapsed and Refractory Multiple Myeloma (RRMM): Indicated for adult patients with multiple myeloma who have undergone at least two prior treatment regimens—specifically including both lenalidomide and a proteasome inhibitor (such as bortezomib)—and have demonstrated disease progression on or within 60 days of completing their last therapy. It is administered in highly structured cycles, typically in combination with low-dose dexamethasone.
• Kaposi Sarcoma (KS): Utilized under professional specialist protocols for managing AIDS-related Kaposi sarcoma when highly active antiretroviral therapy (HAART) yields inadequate responses, or for managing Kaposi sarcoma in adults who are HIV-negative.

2. Comprehensive Mechanism of Action (MOA)

• E3 Ubiquitin Ligase Complex Reprogramming: Pomalidomide binds directly and with high affinity to Cereblon (CRBN), a vital component of the cullin-RING E3 ubiquitin ligase enzyme complex. This binding alters the structural binding properties of the ligase, causing the selective ubiquitination and rapid intracellular degradation of two essential lymphoid transcription proteins: Ikaros (IKZF1) and Aiolos (IKZF3). The destruction of these proteins arrests the growth of abnormal plasma cell populations.
• Direct Cytotoxicity & G1 Cell Cycle Arrest: It works directly on tumor colonies to stop the cell cycle at the G1/S phase interface, inducing systematic apoptosis (programmed cell death) even in myeloma cell lines that have grown resistant to lenalidomide.
• Angiogenesis Suppression: It hinders the blood supply lines of the tumor by blocking crucial angiogenic pathways, effectively stopping the release of Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF), which cuts off microvessel formation in the bone marrow microenvironment.
• Immune System Augmentation: It suppresses inflammatory cytokines (such as tumor necrosis factor-alpha [TNF-$\alpha$] and Interleukin-6 [IL-6]) while stimulating T-cell and Natural Killer (NK) cell activation, turning the body's natural immune defenses against residual cancer cells.

3. Storage, Stability, and Handling Protocols

• Temperature Matrix: Store Pomalong 4mg Capsules safely in their original moisture-resistant primary bottle packaging at controlled room temperature, strictly between 20°C to 25°C (68°F to 77°F), with transient transport excursions permitted down to 15°C and up to 30°C. Protect the stock from high environmental humidity, steam, and direct solar exposure.
• Handling Precautions: Capsules must be swallowed whole with water at the same time each day, either with or without food. Do not break, chew, crush, or open the capsules. Healthcare personnel, pharmacy staff, or caregivers who are pregnant or planning to become pregnant must never handle open or structurally compromised capsules due to severe risks associated with transdermal drug dust exposure.

Potential Side Effects of Pomalong 4mg

• Hematological Toxicity (Severe Myelosuppression): Profound neutropenia (leaving patients highly vulnerable to opportunistic, life-threatening bacterial or viral infections), severe thrombocytopenia (causing bruising or mucosal bleeding risks), and severe anemia.
• Thromboembolic Hazards (Boxed Warning Risk): A significantly elevated risk for deep vein thrombosis (DVT), pulmonary embolism (PE), and cardiovascular events. Prophylactic anticoagulation is standard during therapy.
• Systemic Neuropathy & Fatigue: Moderate to severe peripheral neuropathy (numbness, burning, or tingling in the extremities), dizziness, confusion, and profound systemic fatigue.
• Gastrointestinal Distress: Chronic diarrhea, severe constipation, nausea, vomiting, and diminished appetite leading to unwanted weight loss.

Export Documentation & Global Trade Compliance

• Certificate of Analysis (COA): Providing verifiable batch analysis verifying the exact $4\text{ mg}$ Pomalidomide concentration, active pharmaceutical dissolution profiles, and absolute chemical purity indices.
• Certificate of Origin (COO): Authenticating true manufacturing provenance within verified, registered Indian production lines.
• Customs-Compliant Manifesting: Precision shipping manifests, clean packing lists, and commercial invoicing marked with correct global harmonized system (HS) codes for seamless clearance.

PRESCRIPTION MEDICINE IS: YES

Disclaimer: This structural product review is prepared strictly for international business-to-business (B2B) trade procurement, wholesale distribution networks, and digital optimization indexing. Pomalong 4mg (Pomalidomide) is a highly restricted, high-potency prescription cytostatic medication. It possesses strong teratogenic properties similar to thalidomide and can cause severe, life-threatening human birth defects. It must be prescribed and dispensed exclusively through registered risk evaluation and mitigation strategy (REMS) equivalent programs and must never be used during pregnancy.

• www.ernestimpex.com
• www.ernestvision.com
• www.oncologymedicinesupplier.com
• www.ernestpharmaceuticals.com